Prenatal diagnosis of congenital Chagas' disease (American trypanosomiasis)

The prenatal diagnosis of congenital transmission of Chagas' disease in a pregnant woman with the indeterminate form of the disease is reported. Sonography revealed fetal hydrops at 31 weeks' gestation. Anti-Trypanosoma cruzi IgM and IgG antibodies were negative in the fetal blood sampled by cordocentesis, but T. cruzi trypomastigotes were found in its buffy coat. Owing to anemia, in utero exchange transfusion was undertaken, but fetal demise ensued. Labor was induced and a stillborn infant weighing 2030 g was delivered. The pathological examination revealed placentitis and meningoencephalitis, myocarditis and splenitis in the stillborn fetus. Amastigotes were found in the myocardium, brain and placenta. Copyright © 2004 John Wiley & Sons, Ltd.     

Congenital limb deficiencies in newborn infants: prevalence,characteristics and prenatal diagnosis

Congenital limb deficiency (CLD) occurs in 0.54 to 0.59/1000 live-born infants and varies according to its anatomic location, type and cause. Our aim was to present a fetus with a prenatal ultrasonographic diagnosis of CLD (transverse reduction deficiency of the left upper limb), and to determine the prevalence and clinical characteristics of CLD at a tertiary medical centre in Israel. Among 78 500 live-born infants, there were 24 cases of CLD (0.31/1000): 45.8% of the CLD cases with affected upper limbs, 45.8% with affected lower limbs, and 8.4% with both limbs affected; 88.4% of the limb deficiencies were longitudinal and 11.6% were transverse; and, 33.3% (8/24) of the affected newborn infants had additional congenital anomalies. We conclude that CLD is not an infrequent finding in live-born infants. Comprehensive ultrasonography of the fetus allows early prenatal diagnosis of CLD and provides the parents with important information and helps them in their decision regarding the fate of the pregnancy. Copyright © 2003 John Wiley & Sons, Ltd.     

响应曲面法优化物理活化制备羊骨基活性炭工艺

为通过物理活化法制备羊骨活性炭,采用响应曲面(Response surface methodology,RSM)实验设计,以活化温度、活化时间、CO2流量为试验因素,以碘吸附值为响应值,建立数学模型,工艺条件进行优化。结果表明:最佳工艺条件为活化温度476.05℃、活化时间9.34 min、CO2流量159.4 mL/min,在此条件下碘吸附值为411 mg/g;通过对碘吸附值曲面方程和二次多项回归方程解逆矩阵得知该方程的预测值与实际值之间具有较好的拟合度。     

CoZn-ZIF/MgAl-LDHs制备及其对碘吸附性能的研究

通过在双金属氢氧化物MgAl-LDHs表面定向固定纳米尺度的CoZn-ZIF,并原位生长形成CoZn-ZIF/MgAl-LDHs复合材料.利用扫描电子显微镜(SEM),傅里叶变换红外光谱仪(FT-IR),X射线衍射(XRD)和热重差热综合热分析仪(TGA/DSC)分析手段对材料进行表征,考察CoZn-ZIF/MgAl-LDHs复合材料对正己烷中碘分子的吸附行为,讨论了吸附时间和吸附温度对吸附性能的影响.此外,还对吸附过程的吸附动力学和热力学进行详细的研究,考察准一级和准二级动力学模型,Langmuir和Freundlich等温吸附模型探究该材料的吸附机理.实验结果表明,CoZn-ZIF/MgAl-LDHs对碘的吸附行为符合准二级动力学模型,吸附平衡时间为225 min.通过Langmuir等温方程得到最大平衡吸附量为344.3322 mg·g~(-1),碘的吸附过程更好地拟合Freundlich等温方程,说明反应是多分子层吸附过程,同时,由热力学数据得知该吸附是以物理吸附为主的放热过程,降低温度对吸附过程更有利.     

人群的自然和社会属性分类下PM2.5对心血管疾病的影响

为了研究人群在自然属性和社会属性分类下的效应修饰作用,利用2005~2011年北京市大气PM_2.5日均浓度、气象要素及循环系统疾病每日死亡人数数据,根据不同年龄、性别及学历将人群分组,采用时间序列的半参数广义相加模型（GAM）,定量评价大气PM_2.5对居民循环系统疾病死亡人数的影响.单污染物模型和多污染物模型结果表明,PM_2.5为影响循环系统疾病每日死亡人数的主要大气污染物.北京市空气中PM_2.5的浓度每增加10μg/m³,循环系统疾病总死亡人数增加0.50%（95% CI：0.36,0.63）.不同人群的易感程度不同,各人群死亡人数的增加范围为0.23~0.71%,女性、60~74岁人群、文盲人群的健康风险相对较高.在文盲人群中,老年（60+）女性占比为66.2%,为了分离社会属性人群分类中可能存在的自然属性因素干扰,本文去除其中老年、女性这两个混杂因素的影响,文盲人群健康风险仍然大于较高学历的人群.年龄和性别因素叠加在学历因素上,可能加大低学历人群的健康风险,对于这部分叠加了自然因素和社会因素双重敏感性的人群应给与重点关注.     

纳米Fe掺杂MIL-101(Cr)及其吸附放射性碘研究

目的改进并提高MIL-101(Cr)吸附气态碘单质的性能,以期用于核事故放射性碘富集吸收。方法通过水热法制备MIL-101(Cr)材料,并利用纳米Fe掺杂改性,运用SEM、XRD等对掺杂前后的材料进行表征。将材料在75℃条件下对气态碘单质进行吸附,并比较不同Fe掺杂量下材料对气态碘吸附性能的差异。结果纳米Fe成功掺杂于基体材料MIL-101中,并对基体材料晶体结构无破坏作用。吸附性能研究表明,掺杂纳米Fe质量分数为1%的Fe@MIL-101吸附性能最优,对气态碘的饱和吸附量可达3.42 g(I2)/g(MIL-101)。结论纳米Fe掺杂改性的MIL-101材料在高温条件下对气态碘单质具有良好的吸附效果,有望应用于核反应堆事故中对放射性碘的富集或捕集。     

Diagnosis of cardiac defects: where we've been,where we are and where we're going

There has been tremendous development in the field of prenatal diagnosis of cardiac disease in the last 30 years. Early work centered on the technical aspects of providing an accurate assessment of cardiac structure and function. Techniques of fetal cardiac screening have been developed and utilized throughout the world. More recently, investigators have begun to explore the ramifications of fetal cardiac diagnosis by assessing measures of outcome. In this article, the field of fetal echocardiography, as a screening tool for identifying congenital heart disease, and its impact on disease outcome is reviewed. Copyright © 2002 John Wiley & Sons, Ltd.